Ann: Trading Halt, page-4

I recently sold out my holdings at a loss, but still root for the company to get back on its toes. I may reinvest layer down the line but I dont think this company has many more capital raises in it, in all honesty.

I think AI and Mental Health are both huge markets to be in, however, with diagnosis being only a small part of that, I'm not sure if what MEB has is enough. Ongoing treatment solutions is posed to be the more fruitful slice of the market imo.

just my 2 cents
would be happy to hear otherwise / be proven wrong